ALL MARKETS
FTSE 100
FTSE 250
AIM MARKET

SkinBioTherapeutics.
51 announcements.
Time Date Ticker Company Announcement
15:55 04-12-2024 SBTX SkinBioTherapeutics
Posting of Annual Report and Notice of AGM
15:54 04-12-2024 SBTX SkinBioTherapeutics
Final Results
07:00 04-12-2024 SBTX SkinBioTherapeutics
Notice of Results
11:00 29-11-2024 SBTX SkinBioTherapeutics
Notice of Results
07:00 19-11-2024 SBTX SkinBioTherapeutics
Finalisation of commercial agreement with Croda
14:40 23-10-2024 SBTX SkinBioTherapeutics
Integration update and share price movement
07:00 17-10-2024 SBTX SkinBioTherapeutics
Holding(s) in Company
07:00 16-10-2024 SBTX SkinBioTherapeutics
Issue of Equity and Total Voting Rights
07:00 11-10-2024 SBTX SkinBioTherapeutics
Acquisition and Financial Update
14:02 04-10-2024 SBTX SkinBioTherapeutics
Notice of Investor Meet Company Presentation
07:00 19-09-2024 SBTX SkinBioTherapeutics
Final testing of SkinBiotix by Croda completed
12:49 13-08-2024 SBTX SkinBioTherapeutics
Holding(s) in Company
07:00 02-08-2024 SBTX SkinBioTherapeutics
Investment of £1.56m from new investors
07:00 23-07-2024 SBTX SkinBioTherapeutics
Closure of Convertible Bond Facility
07:00 22-07-2024 SBTX SkinBioTherapeutics
Conversion Notice and Total Voting Rights
07:00 15-07-2024 SBTX SkinBioTherapeutics
Notice of Business Update & Investor Presentation
15:16 28-06-2024 SBTX SkinBioTherapeutics
Conversion Notice and Total Voting Rights
07:00 18-06-2024 SBTX SkinBioTherapeutics
AxisBiotix Acne study reports positive data
07:00 29-05-2024 SBTX SkinBioTherapeutics
Conversion Notice and Total Voting Rights
11:44 11-04-2024 SBTX SkinBioTherapeutics
Holding(s) in Company
07:00 05-04-2024 SBTX SkinBioTherapeutics
Conversion Notice & Total Voting Rights
07:00 22-03-2024 SBTX SkinBioTherapeutics
Half-year Report
07:00 18-03-2024 SBTX SkinBioTherapeutics
New research project and CSO to return to academia
07:00 12-03-2024 SBTX SkinBioTherapeutics
Conversion Notice and Total Voting Rights
09:43 08-03-2024 SBTX SkinBioTherapeutics
Notice of Results
12:41 28-02-2024 SBTX SkinBioTherapeutics
Conversion notice and alternative financing
07:00 27-02-2024 SBTX SkinBioTherapeutics
Positive Interim AxisBiotix Acne study results
07:00 20-02-2024 SBTX SkinBioTherapeutics
Dermatonics to launch Once Heel Balm in AMEA
07:00 09-02-2024 SBTX SkinBioTherapeutics
Conversion Notice and Total Voting Rights
07:31 06-02-2024 SBTX SkinBioTherapeutics
Dermatonics Full Year trading update
07:00 26-01-2024 SBTX SkinBioTherapeutics
Completion of Acquisition of Dermatonics
07:00 25-01-2024 SBTX SkinBioTherapeutics
£5.0m Convertible Bond Facility & First Drawdown
07:00 25-01-2024 SBTX SkinBioTherapeutics
Acquisition of Dermatonics
10:49 29-12-2023 SBTX SkinBioTherapeutics
Result of AGM
08:13 29-12-2023 SBTX SkinBioTherapeutics
Update on transaction timelines to early 2024
07:00 06-12-2023 SBTX SkinBioTherapeutics
Notice of AGM and posting of Annual Report
17:25 30-11-2023 SBTX SkinBioTherapeutics
Final Results
07:00 30-11-2023 SBTX SkinBioTherapeutics
AxisBiotix-Psâ„¢ to launch on Amazon UK
15:37 23-11-2023 SBTX SkinBioTherapeutics
Holding(s) in Company
07:00 22-11-2023 SBTX SkinBioTherapeutics
Update regarding Nominated Adviser and Broker
07:00 21-11-2023 SBTX SkinBioTherapeutics
Result of Retail Offer
07:00 17-11-2023 SBTX SkinBioTherapeutics
Result of Placing
16:33 16-11-2023 SBTX SkinBioTherapeutics
Placing and Retail Offer
16:35 16-11-2023 SBTX SkinBioTherapeutics
Retail Offer
07:25 25-10-2023 SBTX SkinBioTherapeutics
Acne study, Trading and Auditor updates
07:00 19-10-2023 SBTX SkinBioTherapeutics
Extension of Croda contract for SkinBiotixâ„¢
09:00 15-09-2023 SBTX SkinBioTherapeutics
health authority approval for AxisBiotix in France
07:00 05-09-2023 SBTX SkinBioTherapeutics
Update on acne programme
07:00 21-06-2023 SBTX SkinBioTherapeutics
Regulatory Approval
16:46 14-06-2023 SBTX SkinBioTherapeutics
Business progress update
07:00 10-05-2023 SBTX SkinBioTherapeutics
SkinBiotix and AxisBiotix Update